- Home
- NPCE
NPCE
Neuropace Inc.
as 02-21-2025 3:41pm EST
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | MOUNTAIN VIEW |
| Market Cap: | 427.9M | IPO Year: | 2021 |
| Target Price: | $15.29 | AVG Volume (30 days): | 314.8K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.45 - $17.37 | Next Earning Date: | 03-04-2025 |
| Revenue: | $76,452,000 | Revenue Growth: | 27.00% |
| Revenue Growth (this year): | 24.08% | Revenue Growth (next year): | 16.82% |
Stock Insider Trading Activity of Neuropace Inc. (NPCE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Morrell Martha | NPCE | CHIEF MEDICAL OFFICER | Jan 29 '25 | Sell | $15.00 | 300 | $4,500.00 | 86,962 | |
| Morrell Martha | NPCE | CHIEF MEDICAL OFFICER | Jan 24 '25 | Sell | $15.01 | 3,200 | $48,032.00 | 86,962 |
Latest Neuropace Inc. News
NPCE Breaking Stock News: Dive into NPCE Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?
GlobeNewswire
2 days ago
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
Zacks
3 days ago
Integer (ITGR) Misses Q4 Earnings Estimates
GlobeNewswire
3 days ago
NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
GlobeNewswire
4 days ago
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
MT Newswires
8 days ago
Update: NeuroPace Prices $65 Million Public Offering; Shares Jump
MT Newswires
9 days ago
Sector Update: Health Care Stocks Flat to Higher Premarket Friday
GuruFocus.com
9 days ago
NeuroPace Prices $65 Million Offering; Shares Drop in Pre-Market
Compare NPCE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NPCE Neuropace Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.